Exagen IncNASDAQ:XGN
- LAST PRICE2.4300
- TODAY'S CHANGE (%)0.0100 (0.4132%)
- Bid / Lots2.2000/ 1
- Ask / Lots2.6900/ 1
- Open / Previous Close2.4600 / 2.4200
- Day Range
- 52 Week Range
- Volume9,957
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XGN |
|---|---|---|
| 09:32 ET | 124 | 2.46 |
| 09:52 ET | 100 | 2.46 |
| 09:54 ET | 730 | 2.46 |
| 10:51 ET | 200 | 2.46 |
| 11:08 ET | 1100 | 2.46 |
| 12:21 ET | 573 | 2.45 |
| 12:52 ET | 200 | 2.45 |
| 02:26 ET | 1089 | 2.4 |
| 03:20 ET | 1075 | 2.35 |
| 03:45 ET | 280 | 2.35 |
| 03:59 ET | 400 | 2.43 |
Mar 22, 2023
--BTIG Adjusts Price Target on Exagen to $5 From $6, Maintains Buy Rating, from 8:45AM ET on Wednesday Mar 22, 2023 by MT Newswires
8:45AM ET on Wednesday Mar 22, 2023 by MT Newswires
Mar 20, 2023
BRIEF-Exagen Inc Reports Q4 Revenue Of $12.8 Million, from 4:22PM ET on Monday Mar 20, 2023 by Thomson Reuters
4:22PM ET on Monday Mar 20, 2023 by Thomson Reuters-- Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $12.8M, vs. Street Est of $8.7M, from 4:05PM ET on Monday Mar 20, 2023 by MT Newswires
4:05PM ET on Monday Mar 20, 2023 by MT NewswiresExagen Inc. Reports Fourth Quarter and Full Year 2022 Results, from 4:05PM ET on Monday Mar 20, 2023 by GlobeNewswire
4:05PM ET on Monday Mar 20, 2023 by GlobeNewswire
Mar 6, 2023
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023, from 4:05PM ET on Monday Mar 06, 2023 by GlobeNewswire
4:05PM ET on Monday Mar 06, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Exagen Inc | 40.7M | -0.9x | --- |
New York Health Care Inc | 38.9M | 0.0x | --- |
Greenbrook Tms Inc | 36.8M | -0.5x | --- |
Burning Rock Biotech Ltd | 305.0M | -2.1x | --- |
Psychemedics Corp | 30.8M | -27.6x | --- |
Healthcare Solutions Management Group Inc | 46.1M | -1.9x | --- |
Company Information
Exagen Inc. is a commercial-stage life sciences company. The Company offers physicians testing and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. The Company develops and commercializes testing products under its AVISE brand. Its products include AVISE CTD, AVISE Lupus, AVISE APS, AVISE Vasculitis AAV, AVISE SLE Prognostic, AVISE Anti-CarP, AVISE PC4d, AVISE SLE Monitor, AVISE MTX and AVISE HCQ. Its lead testing product, AVISE CTD, enables differential diagnosis for patients presenting with symptoms indicative of a variety of connective tissue diseases (CTD) and other related diseases with overlapping symptoms. Its AVISE brand allows for the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis. Its product portfolio integrates CB-CAPs technology, which is a stable and reliable method for differentially diagnosing SLE.
Contact Information
- Headquarters
- 1261 Liberty Way Ste CVISTA, CA, United States 92081-8356
- Phone
- 760-560-1501
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Brian Birk
- President, Chief Executive Officer
- John Aballi
- Chief Financial Officer, Corporate Secretary
- Kamal Adawi
- Chief Operating Officer, Chief Business Officer
- Mark Hazeltine
- Independent Director
- Ana Hooker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.7M |
|---|---|
Revenue (TTM) | $45.6M |
Shares Outstanding | 16.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-2.77 |
Book Value | $2.57 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -101.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
